A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

JULY 2018

Volume 4, Number 7

FDA Takes Action Against Teething Products

The U.S. Food and Drug Administration (FDA) has urged manufacturers of over-the-counter benzocaine products to stop marketing them for treating teething pain in infants and children under the age of 2.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy